Exercise Prescription in Children With Hypertrophic Cardiomyopathy

Recruiting N/A Interventional Study
Hypertrophic Cardiomyopathy Without Obstruction
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
10 – 18
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
10 (estimated)
Sponsor
Alder Hey Children's NHS Foundation Trust · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Hypertrophic Cardiomyopathy (HCM) is an inherited cardiac condition that affects the heart muscle of adults and children. Historically, doctors have been cautious about encouraging patients with HCM to exercise, as they were worried it could be unsafe due to the risk of heart problems or emergencies. But recent evidence shows that the risks of exercise for a patient with HCM are far lower than pre…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Undergoing screening for HCM due to a family history or gene-positive * Aged 10 to 18 years (inclusive) * Known to the inherited cardiac conditions clinic at Alder Hey Children's Hospital * Normal cardiac function * Able to complete an exercise log weekly with support from car…
Contacts

Sophia Khan, MbChB MD(Res)

=447557356755

sophia.khan@alderhey.nhs.uk

CONTACT

Lora Capobianco, PhD., CPsychol

lora.capobianco@manchester.ac.uk

CONTACT